Projects per year
Fingerprint
Dive into the research topics where Robert Wesolowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
Training Hematology and Oncology Fellows in Clinical Research
Verschraegen, C. (PI), Garzon, R. (CoPI) & Wesolowski, R. (CoPI)
07/1/20 → 06/30/25
Project: Research
-
CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
Mullick Chowdhury, S., Hong, F., Rolfo, C., Li, Z., He, K., Wesolowski, R., Mortazavi, A. & Meng, L., Feb 2025, In: Biology. 14, 2, 214.Research output: Contribution to journal › Review article › peer-review
Open Access -
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer
Prasath, V., Boutrid, H., Wesolowski, R., Abdel-Rasoul, M., Timmers, C., Lustberg, M., Layman, R. M., Macrae, E., Mrozek, E., Shapiro, C., Glover, K., Vater, M., Budd, G. T., Harris, L., Isaacs, C., Dees, C., Perou, C. M., Johnson, G. L., Poklepovic, A. & Chen, H. & 4 others, , Feb 2025, In: Breast Cancer Research and Treatment. 210, 1, p. 179-189 11 p., e404770.Research output: Contribution to journal › Article › peer-review
-
A First-in-Human Phase I Study of BXQ-350, a First-in-Class Sphingolipid Metabolism Regulator, in Patients with Advanced/Recurrent Solid Tumors or High-Grade Gliomas
Rixe, O., Villano, J. L., Wesolowski, R., Noonan, A. M., Puduvalli, V. K., Wise-Draper, T. M., Curry, R., Yilmaz, E., Cruze, C., Ogretmen, B., Tapolsky, G. & Takigiku, R., Nov 15 2024, In: Clinical Cancer Research. 30, 22, p. 5053-5060 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer
Quiroga, D., Wesolowski, R., Zelinskas, S., Pinette, A., Benner, B., Schwarz, E., Savardekar, H., Johnson, C., Stiff, A., Yu, L., Macrae, E., Lustberg, M., Mrozek, E., Ramaswamy, B. & Carson, W. E., Jan 1 2024, In: Cancer Control. 31Research output: Contribution to journal › Article › peer-review
Open Access -
Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer
Otto-Dobos, L. D., Strehle, L. D., Loman, B. R., Seng, M. M., Sardesai, S. D., Williams, N. O., Gatti-Mays, M. E., Stover, D. G., Sudheendra, P. K., Wesolowski, R., Andridge, R. R., Bailey, M. T. & Pyter, L. M., Dec 2024, In: npj Breast Cancer. 10, 1, 99.Research output: Contribution to journal › Article › peer-review
Open Access